تا ١٥ مهر ميتوانيد براي عضويت در Cancer Immunology Project به تكميل فرم زير اقدام كنيد:
فرم عضويت: http://goo.gl/5wJxCR

صفحه آنلاين:
‏https://usern.tums.ac.ir/Group/Info/CIP

@cip_usern
@usern_net

اسامی برندگان جایزه ی نوبل پزشکی سال 2018 اعلام شد.
به همین مناسبت شما را به تماشای گفتگوی دکتر نیما رضایی با برنامه ی چرخ در شبکه چهار سیما دعوت میکنیم.
@cip_usern

The role of inflammatory cytokines and tumor associated macrophages (TAMs) in microenvironment of pancreatic cancer
Read more:
https://www.linkedin.com/feed/update/urn:li:activity:6456458493862903808/

@cip_usern

Basic understanding and therapeutic approaches to target toll‐like receptors in cancerous microenvironment and metastasis
Read more:
https://www.linkedin.com/feed/update/activity:6457304107924353024

@cip_usern

The promising role of monoclonal antibodies for
immunotherapy of the HIV-associated cancer, non-
Hodgkin lymphoma
For more:
https://www.linkedin.com/feed/update/urn:li:activity:6458647817702375424/

@cip_usern

Immunotherapy of cancers comes of age
Read more:
https://www.linkedin.com/feed/update/activity:6459428167022055424

@cip_usern

برگزاري جلسه معارفه و ارائه نحوه فعاليت پژوهشي در گروه Cancer Immunology Project

#سومين دوره جذب عضو گروه CIP
#عكس_دسته_جمعي
يكم آبان ٩٧
@cip_usern
@usern_net

Cancer cachexia: Diagnosis, assessment, and treatment
For more:
https://www.linkedin.com/feed/update/urn:li:activity:6461186794728759296/

@cip_usern

Passive-specific immunotherapy with monoclonal antibodies for prostate cancer: A systematic review
Read more:
https://www.linkedin.com/feed/update/activity:6463389187079962624

@cip_usern

Roles of Myeloid-Derived Suppressor Cells in Cancer Metastasis: Immunosuppression and Beyond.
Read more:
https://www.linkedin.com/feed/update/activity:6467041505277157376

Dermatofibrosarcoma Protuberans; Case Report of
a Rare Tumor of the Breast.
Read more:
https://www.linkedin.com/feed/update/activity:6469956210970890240

@cip_usern

Radioimmunotherapy in non-Hodgkin lymphoma: Prediction andassessment of response
Read more:
https://www.linkedin.com/feed/update/urn:li:activity:6477561315643662336/

📺 مصاحبه با دکتر رضایی در شبکه ۴ سيما، خبر ساعت ۲۰ در خصوص مراسم سالگرد تاسیس یوسرن

🏷اگر هنوز برای شرکت در این مراسم ثبت نام نکرده اید:

https://goo.gl/forms/GxbtlkFukJ5YJvQC3
یا
https://evnd.co/gUxEY

@usern_net

The promising role of monoclonal antibodies for gastric cancer treatment
Read more:
https://www.linkedin.com/feed/update/urn:li:activity:6501870827573649408

@cip_usern

IL-17 and colorectal cancer: From carcinogenesis to treatment.
Read more:
https://www.linkedin.com/feed/update/urn:li:activity:6510406463985324032/

@cip_usern

#آشنایی_با_اینترست_گروپ_یوسرن

⚜️گروه پژوهشی Cancer Immunology Project در سال 2016 تاسیس شد. این گروه با چاپ 14 مقاله و نگارش دو کتاب با همکاری Elsevier و Springer توانست عنوان برترین اینترست گروپ یوسرن را از آن خود کند.

کانال این گروه در تلگرام:
@cip_usern

ایمیل جهت برقراری ارتباط:
cip.usern@gmail.com

@usern_net

برآمد باد صبح و بوی نوروز
به کام دوستان و بخت پیروز

مبارک بادت این سال و همه سال
همایون بادت این روز و همه روز

گروه CIP فرا رسیدن سال نو را به شما همراهان گرامی تبریک عرض میکند🌸

@cip_usern

Therapeutic cancer vaccines represent a type of active cancer immunotherapy. Clinicians and scientists working on cancer treatment require evidence-based and up-to-date resources relating to therapeutic cancer vaccines.These vaccines provides a reference for cancer treatment for clinicians and presents a well-organized resource for determining high-potential research areas.
This book has been written by supervisors and members of CIP group and been published by Elsevier. Chapters cover cancer immunology, general approaches to cancer immunotherapy, vaccines, tumor antigens, the strategy of cancer vaccines, personalized vaccines, whole-tumor antigen vaccines, protein and peptide vaccines, dendritic cell vaccines, genetic vaccines, candidate cancers for vaccination, obstacles to developing therapeutic cancer vaccines, combination therapy, future perspectives and concluding remarks on therapeutic cancer vaccines.

https://www.elsevier.com/books/vaccines-for-cancer-immunotherapy/rezaei/978-0-12-814039-0

To understand the fundamental interactions between tumor cells and the immune system, immunosurveillance and evolutionally immunoediting hypothesis were proposed. When tumor cells overcome mechanisms of the immune system in the elimination phase, they proceed with the equilibrium and probably escape phases. In each phase, various immune cells and cytokines are involved. Moreover, several mechanisms are considered for the tumor escaping form the immune system, including defect in tumor antigen presentation and recognition, dominance of inhibitory mechanisms and lack of activating effects, and resistant subtypes of tumor cells such as cancer stem cells. 

Read more:
https://www.sciencedirect.com/science/article/pii/B9780128140390000011

https://www.linkedin.com/feed/update/urn:li:activity:6515570644556488704

@cip_usern

Cancer immunotherapy has a long history with the first evidence recorded in the late 19th century. Coley's toxin was firstly used in a patient with sarcoma, and with subsequent regression of the tumor, numerous questions raised. Immunosurveillance and, afterwards, immunoediting hypothesis were described in order to figure out the immune system/tumor cells interactions. In order to overcome tumor immune scape, the third phase of cancer immunoediting, and to empower elimination step, immunotherapeutic modalities have been developed. They can be addressed from different views such as classification according to active or passive and specific or nonspecific approach. Up to now, 40 immunotherapeutics have been approved for cancer treatment by the FDA for approximately 90 indications. The modalities include cytokines, toll-like receptor agonists, monoclonal antibodies (mAbs), radio-labeled mAbs, drug-conjugated mAbs, vaccine, immune checkpoint inhibitors, oncolytic virus, bispecific mAbs, and chimeric antigen receptor T cell therapy.

Read more:
https://www.sciencedirect.com/science/article/pii/B9780128140390000023

https://www.linkedin.com/feed/update/urn:li:activity:6518143579779665920/

@cip_usern

Vaccines have been used as a preventive modality against infectious disease for a long time. The application of vaccines to treat the diseases, which have interactions with the immune system, have revealed a new concept of immunotherapy, known as therapeutic vaccines. Many efforts have been made to utilize this modality in the most efficient way. To optimize the current vaccines, understanding the determinants such as selection of the appropriate antigens, combination of effective adjuvants, application of a delivery system, and administration through the proper route are necessary.

For more:
https://www.sciencedirect.com/science/article/pii/B9780128140390000035

https://www.linkedin.com/feed/update/urn:li:activity:6518474982987689984

@cip_usern